Here's the live share price of SMS Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of SMS Pharmaceuticals has gained 24.01% CAGR. Over the past year, the corresponding return has been 32.18%.
SMS Pharmaceuticals’s current P/E of 32.72x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| SMS Pharmaceuticals | -0.02 | 14.55 | 11.38 | 33.25 | 32.18 | 53.97 | 24.01 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, SMS Pharmaceuticals has gained 32.18% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, SMS Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 311.52 | 313.62 |
| 10 | 315.94 | 314.04 |
| 20 | 315.01 | 311.38 |
| 50 | 297.86 | 298.87 |
| 100 | 274.03 | 282.97 |
| 200 | 254.13 | 266.41 |
In the latest quarter, SMS Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 2.88%, FII holding rose to 0.28%, and public shareholding moved down to 28.77% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 18,59,681 | 0.2 | 59.36 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Dec 24, 2025, 5:17 PM IST | SMS Pharmaceuticals - Announcement under Regulation 30 (LODR)-Acquisition |
| Dec 13, 2025, 1:30 AM IST | SMS Pharmaceuticals - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Dec 04, 2025, 3:29 PM IST | SMS Pharmaceuticals - Announcement under Regulation 30 (LODR)-Credit Rating |
| Nov 26, 2025, 1:53 PM IST | SMS Pharmaceuticals - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 13, 2025, 11:49 PM IST | SMS Pharmaceuticals - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 782.75 Cr. and Equity Capital is Rs. 8.87 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for SMS Pharmaceuticals is ₹311.35 as on Dec 24, 2025.
The SMS Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of SMS Pharmaceuticals is ₹2,760.18 Cr as on Dec 24, 2025.
Today’s highest and lowest price of SMS Pharmaceuticals are ₹320.30 and ₹311.10.
The 52-week high/low is the highest and lowest price at which SMS Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of SMS Pharmaceuticals is ₹335.25 and 52-week low of SMS Pharmaceuticals is ₹175.00 as on Dec 24, 2025.
The SMS Pharmaceuticals has shown returns of -1.36% over the past day, 14.55% for the past month, 11.38% over 3 months, 32.18% over 1 year, 53.97% across 3 years, and 24.01% over 5 years.
P/E ratio of and PB ratio of SMS Pharmaceuticals are 32.72 and 3.79 on Dec 24, 2025. While the company gives a dividend yield of 0.13 per annum.